default author photo

Evelina Tacconelli

University of Verona - Infectious Diseases, Department of Diagnostic and Public Health

SCHOLARLY PAPERS

8

DOWNLOADS

1,701

TOTAL CITATIONS

9

Scholarly Papers (8)

1.

Omicron Neutralizing and Anti-SARS-CoV-2 S-RBD Antibodies in Naïve and Convalescent Populations After Homologous and Heterologous Boosting With an mRNA Vaccine

Number of pages: 16 Posted: 31 Jan 2022
Istituto Zooprofilattico Sperimentale delle Venezie - Laboratory of Experimental Animal Models, Istituto Zooprofilattico Sperimentale delle Venezie, Istituto Zooprofilattico Sperimentale delle Venezie, Istituto Zooprofilattico Sperimentale delle Venezie - Laboratory of Experimental Animal Models, University of Padua, University of Padua - Department of Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Istituto Zooprofilattico Sperimentale delle Venezie, Istituto Zooprofilattico Sperimentale delle Venezie, Istituto Zooprofilattico Sperimentale delle Venezie, Istituto Zooprofilattico Sperimentale delle Venezie, Azienda Ulss 8 Berica, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Istituto Zooprofilattico Sperimentale delle Venezie, Bambino Gesù Children's Hospital - Academic Department of Pediatrics (DPUO), affiliation not provided to SSRN, University of Verona, Istituto Zooprofilattico Sperimentale delle Venezie, Istituto Zooprofilattico Sperimentale delle Venezie, affiliation not provided to SSRN, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, University of Padua - Department of Women’s and Children’s Health and Istituto Zooprofilattico Sperimentale delle Venezie - Laboratory of Experimental Animal Models
Downloads 805 (76,240)

Abstract:

Loading...

omicron, correlate, neutralization, chemiluminescence, SARS-CoV-2

VACCELERATE: Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment

Number of pages: 28 Posted: 24 Jan 2022
University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), affiliation not provided to SSRN, affiliation not provided to SSRN, European University Cyprus, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Antwerp - Vaccine and Infectious Disease Institute, affiliation not provided to SSRN, European University Cyprus, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), European Vaccine Initiative, European University Cyprus, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Assistance Publique-Hôpitaux de Paris - Clinical Investigation Center (CIC 1417), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hospital Universitario La Paz - Servicio de Farmacología Clínica, affiliation not provided to SSRN, Hospital Universitario La Paz - Servicio de Farmacología Clínica, affiliation not provided to SSRN, University of Cologne, affiliation not provided to SSRN, Carlos III Institute of Health - Laboratorio de Referencia en Inmunología, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vilnius University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Karolinska Institutet - Division of Infectious Diseases, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, affiliation not provided to SSRN, affiliation not provided to SSRN, Medical University of Vienna - Department of Clinical Pharmacology, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), European University Cyprus - School of Medicine and Independent
Downloads 200 (378,631)

Abstract:

Loading...

VACCELERATE Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment

Number of pages: 21 Posted: 07 Apr 2022
University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), affiliation not provided to SSRN, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), affiliation not provided to SSRN, affiliation not provided to SSRN, European University Cyprus, European University Cyprus, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Antwerp - Vaccine and Infectious Disease Institute, affiliation not provided to SSRN, European University Cyprus, University of Cologne - Division of Infectious Diseases, European Vaccine Initiative, European University Cyprus, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Assistance Publique-Hôpitaux de Paris - Clinical Investigation Center (CIC 1417), affiliation not provided to SSRN, affiliation not provided to SSRN, Hospital Universitario La Paz - Servicio de Farmacología Clínica, Hospital Universitario La Paz - Servicio de Farmacología Clínica, European University Cyprus, Hospital Universitario La Paz - Servicio de Farmacología Clínica, affiliation not provided to SSRN, University of Cologne, Hacettepe University, Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, affiliation not provided to SSRN, University of Bergen - Influenza Centre, affiliation not provided to SSRN, Vilnius University, University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), affiliation not provided to SSRN, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Karolinska Institutet - Division of Infectious Diseases, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, affiliation not provided to SSRN, affiliation not provided to SSRN, Medical University of Vienna - Department of Clinical Pharmacology, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), European University Cyprus - School of Medicine and Independent
Downloads 32 (1,326,242)
Citation 3

Abstract:

Loading...

SARS-CoV-2, registry, pandemic preparedness, clinical trial, volunteer, vaccination campaign, COVID-19, vaccination network

3.

Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial

Number of pages: 34 Posted: 03 Aug 2022
University of Oslo - Section for Clinical Immunology and Infectious Diseases, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, University of Oslo - Institute of Clinical Medicine, University of Lille, affiliation not provided to SSRN, University of Verona, Hospital Universitario Virgen Macarena - Unidad Clínica de Enfermedades Infecciosas, affiliation not provided to SSRN, Université Libre de Bruxelles (ULB), Medical University of Innsbruck, Government of Portugal - Unidade Local de Saúde de São João, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, Sorbonne University, University of Oslo - Division of Emergencies and Critical Care, University of Claude Bernard Lyon 1, affiliation not provided to SSRN, University of Pécs, National and Kapodistrian University of Athens, University Hospital Brno, University of Basel - University Hospital Basel, Hacettepe University, Technische Universität München (TUM), Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, University of Oslo - Oslo University Hospital, Sorbonne University, University of Oslo - Oslo University Hospital, affiliation not provided to SSRN, Vestre Viken Hospital Trust, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, University of Oslo - Institute of Clinical Medicine, University of Stavanger - Stavanger University Hospital, Hospital Universitario La Paz, Vestre Viken Hospital Trust, University Hospital North Norway, Hospices Civils de Lyon - Service de Médecine Intensive-Réanimation, Akershus University Hospital - Department of Infectious Diseases, Norwegian Institute of Public Health, Sorbonne University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Oslo - Department of Immunology and Transfusion Medicine, Hospices Civils de Lyon - Laboratoire de Virologie, University of Nantes - INSERM, University of Oslo - Oslo University Hospital, Norwegian Institute of Public Health, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, affiliation not provided to SSRN, University of Oslo - Department of Research Support for Clinical Trials and Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP
Downloads 176 (428,796)

Abstract:

Loading...

COVID-19, immunomodulator, safety, baricitinib, JAK inhibitor

4.

Effects of Jak Inhibitors in Adults Hospitalized Due to Covid-19: A Systematic Review and Individual Participant Data Meta-Analysis of Randomized Clinical Trials

Number of pages: 27 Posted: 03 Oct 2024
Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, University of Basel, University of Basel - University Hospital Basel, Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, Basel University - CLEAR Methods Center, University Hospitals of Geneva, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), The Emmes Company, Hospital Universitario de Fuenlabrada, Hospital Universitario de Fuenlabrada, Ospedali Riuniti di Ancona, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Mazandaran University of Medical Sciences, University of Cambridge, NHS Foundation Trust - Cambridge University Hospitals, Hospital Universitario La Paz, Hospital Universitario La Paz, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Hospital Israelita Albert Einstein, Hospital Israelita Albert Einstein, University of Sydney - George Institute for Global Health, Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department, Norwegian Institute of Public Health, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Université Libre de Bruxelles (ULB) - Department of Infectious Disease, Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, Hôpital Bichat, APHP, Université Paris Cité, Université Paris Cité, Université Paris Cité, University of Nantes - INSERM, Sorbonne University, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Section for Clinical Immunology and Infectious Diseases and University of Basel - University Hospital Basel
Downloads 174 (437,795)

Abstract:

Loading...

5.

Real-Life Comparison of Mortality in Non-Hospitalised Patients with SARS-CoV-2 Infection at Risk for Clinical Progression Treated with Molnupiravir or Nirmatrevir Plus Ritonavir During the Omicron Era in Italy: A Nationwide, Observational Study

Number of pages: 35 Posted: 10 May 2023
Magna Graecia University of Catanzaro - Department of Medical and Surgical Sciences, The Italian Medicines Agency (AIFA), University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, Udine University Hospital - Department of Medicine (DAME), Infectious Diseases Clinic, The Italian Medicines Agency (AIFA), San Donato Hospital - Department of Specialised and Internal Medicine, Infectious Diseases Unit, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, University of Catania School of Medicine - Department of Internal and Experimental Medicine, D. Cotugno Hospital - Division Emerging Infectious Disease and High Contagiousness, San Giuseppe Moscati Hospital - Infectious Diseases Unit, Pescara General Hospital - Department of Medicine, Infectious Disease Unit, University of Genoa - Department of Health Sciences (DISSAL), Infermi Hospital, AUSL Romagna - Unit of Infectious Disease, Azienda Ospedaliera Universitaria - Ospedali Riuniti di Ancona, Central Hospital of Bolzano - Department of Infectious Disease, A.O.R. San Carlo - Infectious Diseases Unit, Santa Chiara Hospital - Infectious Diseases Unit, Department of Medical, The Italian Medicines Agency (AIFA), Sapienza University of Rome - Department of Public Health and Infectious Diseases, Sapienza University of Rome - Department of Public Health and Infectious Diseases, University of Torino - Unit of Infectious Diseases, Italian Medicines Agency and The Italian Medicines Agency (AIFA)
Downloads 129 (561,789)

Abstract:

Loading...

COVID-19, SARS-CoV-2, nirmatrelvir/ritonavir, molnupiravir, real-world, effectiveness

6.

Multi-Criteria Decision Analysis to Prioritise Hospital Admission of Patients Affected by COVID-19 in Settings with Hospital-Bed Shortage

Number of pages: 16 Posted: 22 Jul 2020
University of Verona - Division of Infectious Diseases, Verona University Hospital - Infectious Diseases Unit, Infectious Diseases Unit, Department of Diagnostics and Public Health, Verona University Hospital, Infectious Diseases Unit, Department of Diagnostics and Public Health, Verona University Hospital, Department of Economics, University of Otago, University of Antwerp - Laboratory of Medical Microbiology, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health and Independent
Downloads 92 (730,864)
Citation 5

Abstract:

Loading...

COVID-19; Multi Criteria Decision Analysis; Hospitalisation

7.

The Association between Antimicrobial Resistance and HIV Infection: A Systematic Review and Meta-Analysis

Number of pages: 34 Posted: 21 Oct 2020
London School of Hygiene & Tropical Medicine, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, London School of Hygiene & Tropical Medicine - Department of Clinical Research, London School of Hygiene & Tropical Medicine - Department of Clinical Research, London School of Hygiene and Tropical Medicine, London School of Hygiene & Tropical Medicine, London School of Hygiene & Tropical Medicine and London School of Hygiene & Tropical Medicine - Department of Clinical Research
Downloads 52 (1,041,696)
Citation 1

Abstract:

Loading...

AMR, antibiotic resistance, AIDS, HIV

8.

A Lever and a Place to Stand to Predict COVID-19 Progression: Developing a Prognostic Model Based on Day Five from Symptoms Onset

Number of pages: 18 Posted: 17 Mar 2021
Verona University Hospital - Infectious Diseases Unit, University of Verona - Division of Infectious Diseases, University of Verona - Division of Infectious Diseases, University of Verona - Division of Infectious Diseases, University of Verona - Division of Infectious Diseases, University of Verona - Division of Infectious Diseases, University of Verona - Division of Infectious Diseases, University of Verona - Division of Infectious Diseases, University of Verona - Division of Infectious Diseases, University of Verona - Section of Internal Medicine, Azienda Ospedaliera Universitaria Integrata Verona - Cardio-Thoracic Department, University of Verona - Division of Infectious Diseases and University of Verona - Infectious Diseases, Department of Diagnostic and Public Health
Downloads 41 (1,170,409)

Abstract:

Loading...